市場調査レポート
商品コード
1076448
植え込み型心調律管理デバイスの世界市場 - 市場規模・シェア・動向分析:製品別(ペースメーカー、ICD、CRT)、最終用途別(病院、心臓専門センター)、地域別、セグメント別の予測(2022年~2030年)Implantable Cardiac Rhythm Management Device Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICDs, CRT), By End Use (Hospitals, Specialty Cardiac Centers), By Region, And Segment Forecasts, 2022 - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
植え込み型心調律管理デバイスの世界市場 - 市場規模・シェア・動向分析:製品別(ペースメーカー、ICD、CRT)、最終用途別(病院、心臓専門センター)、地域別、セグメント別の予測(2022年~2030年) |
出版日: 2022年04月18日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の植え込み型心調律管理デバイスの市場規模は、2030年までに289億米ドルに達し、2022年~2030年にCAGRで6.2%の成長が予測されています。
CVDにかかりやすい世界の高齢者人口の増加と、これらの疾患の正確かつ効果的な診断に対する需要の高まりが、植え込み型心調律管理(CRM)デバイスの成長を促す要因となっています。
当レポートでは、世界の植え込み型心調律管理デバイス市場について調査分析し、市場の動向、製品・最終用途・地域別の分析、競合分析などを提供しています。
List of figures
Fig. 1 Implantable CRM devices market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Implantable Cardiac Rhythm Management (CRM) devices market revenues, 2021, (USD Millions)
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Market trends & outlook
Fig. 11 Porter's five forces analysis
Fig. 12 PESTLE analysis
Fig. 13 Strategy mapping
Fig. 14 Implantable CRM devices market product outlook:
Fig. 15 Implantable CRM devices market: Product movement analysis
Fig. 16 Segment dashboard
Fig. 17 Global pacemaker market, 2017 - 2030 (USD Million)
Fig. 18 Global ICDS market, 2017 - 2030 (USD Million)
Fig. 19 Global CRT market, 2017 - 2030 (USD Million)
Fig. 20 Implantable CRM devices market end-use outlook:
Fig. 21 Implantable CRM devices market: End-use movement analysis
Fig. 22 Global hospitals market, 2017 - 2030 (USD Million)
Fig. 23 Global specialty cardiac centers market, 2017 - 2030 (USD Million)
Fig. 24 Global others market, 2017 - 2030 (USD Million)
Fig. 25 Regional market place: Key takeaways
Fig. 26 North America implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 27 U.S. implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 28 Canada implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 29 Europe implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 30 Germany implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 31 U.K. implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 32 France implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 33 Italy implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 34 Spain implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 35 Asia Pacific implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 36 Japan implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 37 China implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 38 India implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 39 Australia implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 40 Latin America implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 41 Mexico implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 42 Brazil implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 43 MEA implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 44 South Africa implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 45 Saudi Arabia implantable CRM devices market, 2017 - 2030 (USD Million)
Fig. 46 Company market position analysis
The global implantable cardiac rhythm management devices market size is expected to reach USD 28.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increasing global geriatric population prone to CVD diseases and the demand for accurate and effective diagnostics of these diseases are the factors contributing to the growth of implantable cardiac rhythm management (CRM) devices.
Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Hectic schedules and busy lifestyles are major factors for hypertension among individuals. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Pacemakers are the most implanted devices for conduction disorders and sinus dysfunctions. CRT devices and ICDs are comparatively new and incorporate better technology than their older counterparts.
The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.
Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Implanted pacemakers are majorly used for conduction disorders and sinus dysfunctions.